Publications by authors named "Brian A Gordon"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

8,531

Total Likes

545

Extended Reach

738,497

Social Features

80
U
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients.
Matthew R Brier, Suzanne E Schindler, Amber Salter, Dana Perantie, Nicole Shelley, Bradley Judge, Sarah Keefe, Kristopher M Kirmess, Philip B Verghese, Kevin E Yarasheski

Ann Neurol· September 2024

Videos about Article: user user

2 1 77 2 42

View All Article and Social Media Activity
C
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease.
Omar Abdelmoity, Julie K Wisch, James T Kennedy, Manu Goyal, Andrei Vlassenko, Brian A Gordon

Ann Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.
Hannah de Bruin, Colin Groot, Henryk Barthel, Gérard N Bischof, Ganna Blazhenets, Brian A Gordon

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.
Katherine Gong, Jigyasha Timsina, Muhammad Ali, Yike Chen, Menghan Liu, Brian A Gordon

Mol Neurodegener· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathology.
David A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, Shaney Flores, Stephanie Doering, Brian A Gordon

Res Sq· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting real-world memory clinical cohort heterogeneity: analysis of neuroanatomical subtypes using HYDRA.
Gordon Zhaoqi An, Yunchang Xie, Tammie L S Benzinger, Brian A Gordon, Aristeidis Sotiras

Alzheimers Res Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference proteins to improve Core 1 and Core 2 Alzheimer's disease CSF and plasma biomarkers.
Linda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, Kanta Horie, Joseph Therriault, Brian A Gordon

Brain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of longitudinal sleep monitoring in amyloid-negative and amyloid-positive cognitively unimpaired and mildly impaired older adults.
Taylor J Pedersen, Ruijin Lu, Cristina Toedebusch, Ashley Hess, Rachel Richardson, Brian A Gordon

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting future cognitive impairment in preclinical Alzheimer's disease using multimodal imaging: a multisite machine learning study.
Braden Yang, Tom Earnest, Murat Bilgel, Marilyn S Albert, Sterling C Johnson, Brian A Gordon

medRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and longitudinal changes in cortical thickness and hippocampal volume predict cognitive decline.
Gengsheng Chen, Nicole S McKay, Brian A Gordon, Nelly Joseph-Mathurin, Jingxia Liu

J Alzheimers Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onset.
Haiyan Liu, Thomas W Marsh, Xinyu Shi, Alan E Renton, Kevin M Bowling, Brian A Gordon

Brain· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Austin McCullough, Charles D Chen, Brian A Gordon, Nelly Joseph-Mathurin, Clifford R Jack

Alzheimers Dement· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.
David M Cash, Katy E Morgan, Antoinette O'Connor, Thomas D Veale, Ian B Malone, Brian A Gordon

J Prev Alzheimers Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease.
Kanta Horie, Gemma Salvadó, Rama K Koppisetti, Shorena Janelidze, Nicolas R Barthélemy, Brian A Gordon

Nat Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.
Charles D Chen, Erin E Franklin, Yan Li, Nelly Joseph-Mathurin, Aime L Burns, Brian A Gordon

Acta Neuropathol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.
Constance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, Chiara Zecca, Giancarlo Logroscino, Brian A Gordon

Alzheimers Dement· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed dementia cohort.
Katherine Gong, Jigyasha Timsina, Muhammad Ali, Yike Chen, Menghan Liu, Brian A Gordon

Res Sq· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[C]ER176 images brain inflammation across TSPO genotypes and colocalizes with tau.
Aisling M Chaney, Brian A Gordon

Trends Neurosci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin-proteasome system in the different stages of dominantly inherited Alzheimer's disease.
Haiyan Liu, Quoc Bui, Jason Hassenstab, Brian A Gordon, Tammie L S Benzinger

Alzheimers Dement· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia.
Jorge J Llibre-Guerra, M Victoria Fernandez, Nelly Joseph-Mathurin, Shijia Bian, Kathleen Carter, Brian A Gordon

Nat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.
Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford, Brian A Gordon

Lancet Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyzing heterogeneity in Alzheimer disease using multimodal normative modeling on imaging-based ATN biomarkers.
Sayantan Kumar, Tom Earnest, Braden Yang, Deydeep Kothapalli, Andrew J Aschenbrenner, Brian A Gordon

Alzheimers Dement· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.
David M Cash, Katy E Morgan, Antoinette O'Connor, Thomas D Veale, Ian B Malone, Brian A Gordon

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding brain structure to stage Alzheimer's disease pathology in Down syndrome.
James T Kennedy, Julie K Wisch, Aylin Dincer, June Roman, Brian A Gordon

Alzheimers Dement· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.
Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford, Brian A Gordon

medRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease.
Jiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, Andrew Eck, Babatunde Adeyemo, Brian A Gordon

Netw Neurosci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis